Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Tivicay (Dolutegravir) for the Treatment of HIV-1 Infection

Drug Name (Brand / Generic)

Tivicay / dolutegravir

Company / Licensee

ViiV Healthcare

Therapy Class

Antiretroviral drug

Product Description

Integrase inhibitor

Current Indication

HIV-1 infection

Market Sector

Anti-infectives

Development Status

Approved in the US, Canada and Scotland
Expand

Go Top